BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.79B
AUM Growth
-$8.56B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$159M
2
+$98.3M
3
+$70.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$67.8M
5
REPL icon
Replimune Group
REPL
+$41.9M

Top Sells

1
+$9.45B
2
+$337M
3
+$198M
4
SWTX
SpringWorks Therapeutics
SWTX
+$69.4M
5
ROIV icon
Roivant Sciences
ROIV
+$48.1M

Sector Composition

1 Healthcare 98.37%
2 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$508K 0.01%
251,727
-738,201
77
$374K ﹤0.01%
199,671
78
$303K ﹤0.01%
13,331
-1,580,669
79
$290K ﹤0.01%
45,027
80
$287K ﹤0.01%
2,177,499
-1,355,261
81
$147K ﹤0.01%
+10,607
82
$16.2K ﹤0.01%
833,333
83
– –
-444,864
84
– –
-964,851
85
– –
-106,197
86
– –
-413,481
87
– –
-124,986
88
– –
-3,810,248
89
– –
-1,292,966
90
– –
-3,061,224
91
– –
-8,131,678
92
– –
-150,346
93
– –
-100,000
94
– –
-1,127,782
95
– –
-166,347
96
– –
-3,140,473
97
– –
-2,999,846
98
– –
-235,220
99
– –
-31,692
100
– –
-215,800
1 2 3
4
5